sequencing (Pyrosequencing Inc)
86
Structured Review
Pyrosequencing Inc
sequencing
Sequencing, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing/sequencing/us12649918-2222-3-5
Average 86 stars, based on 1 article reviews
Sequencing, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing/sequencing/us12649918-2222-3-5
Average 86 stars, based on 1 article reviews
sequencing - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Sequencing:Article Title: Bi-functional complexes and methods for making and using such complexes Article Snippet: This method of Article Title: 251 Molecular Profiling guided treatment in refractory solid tumors: Practical impact and clinical responses. Experience of a single center Article Snippet: s S43 Conclusions: This study identified the FGFR3/AKT axis as an escape pathway responsible for trastuzumab resistance in GC, thus candidating dovitinib as potential agent to modulate this resistance.. No conflict of interest. Next-Generation Sequencing:Article Title: Bi-functional complexes and methods for making and using such complexes Article Snippet: This method of Article Title: 251 Molecular Profiling guided treatment in refractory solid tumors: Practical impact and clinical responses. Experience of a single center Article Snippet: s S43 Conclusions: This study identified the FGFR3/AKT axis as an escape pathway responsible for trastuzumab resistance in GC, thus candidating dovitinib as potential agent to modulate this resistance.. No conflict of interest. Expressing:Article Title: Bi-functional complexes and methods for making and using such complexes Article Snippet: This method of Article Title: 251 Molecular Profiling guided treatment in refractory solid tumors: Practical impact and clinical responses. Experience of a single center Article Snippet: s S43 Conclusions: This study identified the FGFR3/AKT axis as an escape pathway responsible for trastuzumab resistance in GC, thus candidating dovitinib as potential agent to modulate this resistance.. No conflict of interest. Immunohistochemistry:Article Title: Bi-functional complexes and methods for making and using such complexes Article Snippet: This method of Article Title: 251 Molecular Profiling guided treatment in refractory solid tumors: Practical impact and clinical responses. Experience of a single center Article Snippet: s S43 Conclusions: This study identified the FGFR3/AKT axis as an escape pathway responsible for trastuzumab resistance in GC, thus candidating dovitinib as potential agent to modulate this resistance.. No conflict of interest. Amplification:Article Title: Bi-functional complexes and methods for making and using such complexes Article Snippet: This method of Article Title: 251 Molecular Profiling guided treatment in refractory solid tumors: Practical impact and clinical responses. Experience of a single center Article Snippet: s S43 Conclusions: This study identified the FGFR3/AKT axis as an escape pathway responsible for trastuzumab resistance in GC, thus candidating dovitinib as potential agent to modulate this resistance.. No conflict of interest. Chromogenic In Situ Hybridization:Article Title: Bi-functional complexes and methods for making and using such complexes Article Snippet: This method of Article Title: 251 Molecular Profiling guided treatment in refractory solid tumors: Practical impact and clinical responses. Experience of a single center Article Snippet: s S43 Conclusions: This study identified the FGFR3/AKT axis as an escape pathway responsible for trastuzumab resistance in GC, thus candidating dovitinib as potential agent to modulate this resistance.. No conflict of interest. Fluorescence In Situ Hybridization:Article Title: Bi-functional complexes and methods for making and using such complexes Article Snippet: This method of Article Title: 251 Molecular Profiling guided treatment in refractory solid tumors: Practical impact and clinical responses. Experience of a single center Article Snippet: s S43 Conclusions: This study identified the FGFR3/AKT axis as an escape pathway responsible for trastuzumab resistance in GC, thus candidating dovitinib as potential agent to modulate this resistance.. No conflict of interest. |